A randomized controlled trial of a distress screening, consultation, and targeted referral system for family caregivers in oncologic care
- PMID: 38363002
- PMCID: PMC11250988
- DOI: 10.1002/pon.6301
A randomized controlled trial of a distress screening, consultation, and targeted referral system for family caregivers in oncologic care
Abstract
Objective: Distress screening is standard practice among oncology patients, yet few routine distress screening programs exist for cancer caregivers. The objective of this study was to demonstrate the feasibility, acceptability, and preliminary efficacy of Cancer Support Source-CaregiverTM (CSS-CG, 33-item), an electronic distress screening and automated referral program with a consultation (S + C) to improve caregiver unmet needs, quality of life, anxiety, depression, and distress relative to Enhanced Usual Care (EUC; access to educational materials).
Method: 150 caregivers of patients with varying sites/stages of cancer were randomized to S + C or EUC and completed assessments at baseline, 3-months post-baseline, and 6-months post-baseline. A subset of participants (n = 10) completed in-depth qualitative interviews.
Results: S + C was feasible: among 75 caregivers randomized to S + C, 66 (88%) completed CSS-CG and consultation. Top concerns reported were: (1) patient's pain and/or physical discomfort; (2) patient's cancer progressing/recurring; and (3) feeling nervous or afraid. Differences between groups in improvements on outcomes by T2 and T3 were modest (ds < 0.53) in favor of S + C. Qualitative data underscored the helpfulness of S + C in connecting caregivers to support and helping them feel cared for and integrated into cancer care.
Conclusions: S + C is feasible, acceptable, and yields more positive impact on emotional well-being than usual care. Future studies will examine programmatic impact among caregivers experiencing higher acuity of needs, and benefits of earlier integration of S + C on caregiver, patient, and healthcare system outcomes.
Keywords: cancer; distress screening; family caregivers; oncology; psycho-oncology; psychosocial; referral; unmet needs.
© 2024 The Authors. Psycho-Oncology published by John Wiley & Sons Ltd.
Conflict of interest statement
Conflicts of Interest
Dr. Applebaum receives support from Blue Note Therapeutics and Beigene
Dr. Zaleta reports previous institutional research grants from Astellas Pharma, Boston Scientific Foundation, Novartis, Seagen; advisory funding from BeiGene, Bristol Myers Squibb; all funds were directed to Cancer Support Community.
Dr. Miller reports institutional research grants from Astellas Pharma, BeiGene, Bristol-Myers Squibb, Genentech (a member of the Roche Group), Geron, Gilead Sciences, GlaxoSmithKline, Janssen Pharmaceuticals/Janssen Oncology, Merck, Novartis, Pfizer, Seagen, Taiho Oncology, and Takeda Oncology.
Dr. Schofield, Ms. Gebert, Ms. Behrens, Ms. Loschiavo, Dr. Shaffer, Ms. Levin, Ms. Dannaoui and Ms. Bellantoni report nothing to disclose.
References
-
- Kent EE, Mollica MA, Buckenmaier S, Wilder Smith A. The Characteristics of Informal Cancer Caregivers in the United States. Seminars in Oncology Nursing. 2019;35(4):328–332. - PubMed
-
- What Is a Cancer Caregiver? 2023; https://www.cancer.org/treatment/caregivers/what-a-caregiver-does/who-an.... Accessed April 16, 2023.
-
- Christakis NA, Allison PD. Mortality after the hospitalization of a spouse. N Engl J Med. 2006;354(7):719–730. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
